Medtronic Acquires Klue to Bolster its Personalized Closed Loop Technology for Diabetes Management
Shots:
- Medtronic acquired Klue to incorporate its technology into Medtronic’s Personalized Closed Loop (PCL) insulin pump system to transform diabetes management. Medtronic will leverage Klue’s technology to enhance its market analytics and CGM technology to aid people utilizing MDI for avoiding high/ low glucose events
- Klue's technology utilizes activity trackers and analytics technology in conjunction with AI software to detect when a user is eating a meal and provide real-time insights into eating behaviors
- Medtronic’s PCL system is designed for automatic insulin delivery and has received the FDA’s BT designation in Feb’2019. Additionally- Medtronic has acquired Nutrino Health- both the acquisitions strengthen its capabilities in integration of AI into diabetes management systems
Click here to read full press release/ article | Ref: Medtronic | Image: Klue
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com
